How it started

Cephalalgia, Supplement

Volumn 21, Issue 1, 2001, Pages 2-5

  Humphrey, P P A ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b Advanced Medicine Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERGOTAMINE; METHYSERGIDE; NARATRIPTAN; PIZOTIFEN; PLACEBO; RECEPTOR SUBTYPE; RESERPINE; SEROTONIN 1 AGONIST; SEROTONIN 1 RECEPTOR; SEROTONIN 1B AGONIST; SEROTONIN 1D AGONIST; SEROTONIN 1F RECEPTOR; SEROTONIN 2 RECEPTOR; SEROTONIN 7 RECEPTOR; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR; SUMATRIPTAN; VASOCONSTRICTOR AGENT;

ANALGESIA; ARTERY DILATATION; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG MARKETING; DRUG MECHANISM; DRUG SELECTIVITY; HEADACHE; HUMAN; IRRITABLE COLON; MEDICAL RESEARCH; MIGRAINE; NONHUMAN; ORGAN DISTRIBUTION; PATHOGENESIS; PATHOPHYSIOLOGY; PHARMACIST; PUBLICATION; SHORT SURVEY; SUPERFICIAL TEMPORAL ARTERY; TREATMENT OUTCOME; VASCULAR RESISTANCE; VISCERAL PAIN;

EID: 0035740922     PISSN: 08001952     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-2982.2001.021s1002.x     Document Type: Short Survey

References (9)

1. Mechanism of migraine headache and action of ergotamine tartrate
2. Focal headache during balloon inflation in the internal carotid and middle cerebral arteries
3. Sensitization of meningeal sensory neurons and the origin of headaches
4. Comparative trials of serotonin antagonists in the management of migraine
5. A rational approach to identifying a fundamentally new drug for the treatment of migraine
6. The selective closure of feline carotid arteriovenous anastomoses. (AVAs) by GR 43175
7. 1-like receptor agonist, for the acute treatment of severe migraine
8. Subcutaneous sumatriptan during the migraine aura